SageView Advisory Group, LLC

Position in PFE — Pfizer Inc

CIK 1914558 NEWPORT BEACH, CA

Position in PFE

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$1,244,622

-$275,236 QoQ

Shares Held

51,687

-4.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#1,194

of 2,821 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

SageView Advisory Group, LLC holds $31,073,717 across 11 Drug Manufacturers - General names. PFE ranks #6 (4.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	11,047	$13,250,104
2	JNJ	Johnson & Johnson	19,763	$5,019,209
3	ABBV	AbbVie Inc.	16,291	$4,099,467
4	MRK	Merck & Co., Inc.	25,250	$3,244,625
5	AMGN	Amgen Inc	4,580	$1,658,509
6	PFE	Pfizer Inc This page	51,687	$1,244,622
7	GILD	Gilead Sciences, Inc.	8,588	$1,085,007
8	BMY	Bristol Myers Squibb Co	9,232	$531,947

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,244,622	51,687	-4.5%	Shares	Sole	2026-08-10
2026-03-31	$1,519,858	54,126	-13.7%	Shares	Sole	2026-08-10
2025-12-31	$1,561,653	62,717	+6.5%	Shares	Sole	2026-02-17
2025-09-30	$1,500,695	58,897	+15.8%	Shares	Sole	2025-11-13
2025-06-30	$1,233,185	50,874	-11.3%	Shares	Sole	2025-08-13
2025-03-31	$1,454,059	57,382	+21.5%	Shares	Sole	2025-05-19
2024-12-31	$1,253,330	47,242	+57.5%	Shares	Sole	2025-02-13
2024-09-30	$868,228	30,001	-39.2%	Shares	Sole	2024-11-14
2024-06-30	$1,379,861	49,316	+9.1%	Shares	Sole	2024-08-15
2023-12-31	$1,300,904	45,186	+2.2%	Shares	Sole	2024-03-06
2023-09-30	$1,466,544	44,213	+49.0%	Shares	Sole	2023-11-03
2023-06-30	$1,088,441	29,674	+8.6%	Shares	Sole	2023-08-11
2023-03-31	$1,115,022	27,329	+94.4%	Shares	Sole	2023-05-02
2022-12-31	$720,485	14,061	—	Shares	Sole	2023-02-15
No filing history on record for this holder in this stock.